- Home
- STXS vs AMRN Comparison
STXS vs AMRN Comparison
Compare STXS & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STXS
- AMRN
- Stock Information
- Founded
- STXS 1990
- AMRN 1989
- Country
- STXS United States
- AMRN Ireland
- Employees
- STXS N/A
- AMRN 275
- Industry
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- STXS Health Care
- AMRN Health Care
- Exchange
- STXS Nasdaq
- AMRN Nasdaq
- Market Cap
- STXS 189.8M
- AMRN 189.2M
- IPO Year
- STXS 2004
- AMRN 1993
- Fundamental
- Price
- STXS $2.27
- AMRN $0.46
- Analyst Decision
- STXS Strong Buy
- AMRN Buy
- Analyst Count
- STXS 2
- AMRN 1
- Target Price
- STXS $4.50
- AMRN N/A
- AVG Volume (30 Days)
- STXS 457.1K
- AMRN 1.7M
- Earning Date
- STXS 11-11-2024
- AMRN 10-30-2024
- Dividend Yield
- STXS N/A
- AMRN N/A
- EPS Growth
- STXS N/A
- AMRN N/A
- EPS
- STXS N/A
- AMRN N/A
- Revenue
- STXS $25,143,000.00
- AMRN $241,021,000.00
- Revenue This Year
- STXS $1.16
- AMRN N/A
- Revenue Next Year
- STXS $55.65
- AMRN N/A
- P/E Ratio
- STXS N/A
- AMRN N/A
- Revenue Growth
- STXS N/A
- AMRN N/A
- 52 Week Low
- STXS $1.66
- AMRN $0.43
- 52 Week High
- STXS $3.29
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- STXS 51.98
- AMRN 40.30
- Support Level
- STXS $2.20
- AMRN $0.43
- Resistance Level
- STXS $2.46
- AMRN $0.50
- Average True Range (ATR)
- STXS 0.14
- AMRN 0.03
- MACD
- STXS -0.01
- AMRN 0.00
- Stochastic Oscillator
- STXS 42.71
- AMRN 30.00
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.